Woongjin Co., Ltd. (KRX:016880)
South Korea
· Delayed Price · Currency is KRW 1,920.00
-110.00 (-5.42%)
Mar 9, 2026, 3:30 PM KST
Woongjin Revenue
Woongjin had revenue of 325.17B KRW in the quarter ending September 30, 2025, with 30.52% growth. This brings the company's revenue in the last twelve months to 1.09T, up 8.73% year-over-year. In the year 2024, Woongjin had annual revenue of 1.01T, down -1.03%.
Revenue (ttm)
1,092.76B
Revenue Growth
+8.73%
P/S Ratio
0.14
Revenue / Employee
1.18B
Employees
928
Market Cap
149.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,008.11B | -10.47B | -1.03% |
| Dec 31, 2023 | 1,018.58B | -31.26B | -2.98% |
| Dec 31, 2022 | 1,049.84B | 69.98B | 7.14% |
| Dec 31, 2021 | 979.87B | 93.63B | 10.56% |
| Dec 31, 2020 | 886.24B | 66.32B | 8.09% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gridwiz | 121.79B |
| JLK, Inc. | 3.26B |
| HS HYOSUNG | 1,820.78B |
| Aprogen Medicines | 126.09B |
| HLB GLOBAL | 103.52B |
| KPX Holdings | 1,204.40B |
| Singsong Holdings | 190.20B |
| KG Chemical | 8,938.50B |